PharmaBoardroom

Would the Last Pharmaceutical Investor in Europe Please Turn the…

EFPIA’s Nathalie Moll highlights how Europe can reverse its decline in the global medical research standings and once again make the continent a…

Alzheimer’s Disease Treatment: Canadian-Led Innovation…

Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen's aducanumab on the search for Alzheimer's Disease (AD) treatments, and…

Sustaining the Vaccines Ecosystem Benefits Public Health

Francois Sandre, Head of Asia & JPAC for Sanofi Pasteur outlines the importance of a sustainable global vaccine ecosystem and why a value-based…

COVID-19: A Material Disruptor

Regular PharmaBoardroom contributor David Crean looks at how the ongoing global coronavirus outbreak has impacted the global economy, how the…

USMCA Sets a New Standard for International Trade

Jonathan Kimball of the Association for Accessible Medicines (AAM) in the USA outlines why the signing of the US-Mexico-Canada Agreement (USMCA) in…

Politics & Markets: The Role of the Private Sector in…

Brendan Shaw outlines the long road still to travel to meet the UN Sustainable Development goal of ensuring basic healthcare financing for every…

Coronavirus Poised to Undermine China’s Healthcare Miracle

Eurasia Group's Aditya Bhattacharji examines the unfolding coronavirus outbreak, the prospects for China's political and economic stability, and how…

Bringing Patient Experience to Regulatory Decision-Making:…

Takeda's Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug development and the regulatory…

Opportunities to Fix Medicare Part D

The Association for Accessible Medicines' Chip Davis outlines the ways in which the US Medicare programme needs updating in order to promote generic…

Creating a Data-Driven Research Ecosystem with Patients at the…

Health Catalyst’s Elia Stupka explains why and how patients must be kept at the centre of the healthcare systems of the future, even as they become…

A More Measured Tone at J.P. Morgan Healthcare Conference 2020

David Crean summarises the mood at the recent J.P. Morgan Healthcare Conference 2020 in San Francisco, noting a more subdued atmosphere than previous…

Global Pharma has Reinvented R&D: Will Canadian Start-Ups…

John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global…

Tagged with Opinion